10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000950170-23-020105 |
| Period End Date | 20230331 |
| Filing Date | 20230510 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | talk-20230331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
52 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$125.08M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$138.54M | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$9.64M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$12.46M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$4.37M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$3.81M | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
163.12M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
161.16M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$152.56M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
163.12M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$141.36M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
161.16M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$563.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$677.00K | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$2.34M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$2.53M | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$491.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$518.00K | USD | Point-in-time |
| Total assets |
Assets
|
$156.25M | USD | Point-in-time |
| Total assets |
Assets
|
$144.78M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$7.67M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$6.46M | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$4.12M | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$4.36M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilitiesCurrent
|
$16.50M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilitiesCurrent
|
$9.80M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$21.60M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$27.32M | USD | Point-in-time |
| Warrant liabilities |
WarrantLiabilitiesNonCurrent
|
$1.13M | USD | Point-in-time |
| Warrant liabilities |
WarrantLiabilitiesNonCurrent
|
$939.00K | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$418.00K | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$461.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$28.72M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$23.14M | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 5) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock of $0.0001 par value Authorized: 1,000,000,000 shares at March 31, 2023 and December 31, 2022; Issued and outstanding: 163,119,345 and 161,155,030 shares at March 31, 2023 and December 31,2022,respectively |
CommonStockValue
|
$16.00K | USD | Point-in-time |
| Common stock of $0.0001 par value Authorized: 1,000,000,000 shares at March 31, 2023 and December 31, 2022; Issued and outstanding: 163,119,345 and 161,155,030 shares at March 31, 2023 and December 31,2022,respectively |
CommonStockValue
|
$16.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$381.58M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$378.72M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-251.20M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-259.96M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$127.54M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$121.64M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$144.78M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$156.25M | USD | Point-in-time |
Income Statement
34 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$30.15M | USD | 1 Quarter |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$33.34M | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$16.59M | USD | 1 Quarter |
| Cost of revenues |
CostOfRevenue
|
$15.13M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$16.75M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$15.02M | USD | 1 Quarter |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$5.35M | USD | 1 Quarter |
| Research and development, net |
ResearchAndDevelopmentExpense
|
$5.04M | USD | 1 Quarter |
| Clinical operations, net |
OtherCostAndExpenseOperating
|
$1.60M | USD | 1 Quarter |
| Clinical operations, net |
OtherCostAndExpenseOperating
|
$1.78M | USD | 1 Quarter |
| Sales and marketing |
SellingAndMarketingExpense
|
$13.47M | USD | 1 Quarter |
| Sales and marketing |
SellingAndMarketingExpense
|
$21.41M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$5.36M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$8.01M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$25.79M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$36.23M | USD | 1 Quarter |
| Operating loss |
OperatingIncomeLoss
|
$21.21M | USD | 1 Quarter |
| Operating loss |
OperatingIncomeLoss
|
$9.04M | USD | 1 Quarter |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$-869.00K | USD | 1 Quarter |
| Financial income, net |
InterestAndDebtExpenseIncome
|
$-424.00K | USD | 1 Quarter |
| Loss before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$20.34M | USD | 1 Quarter |
| Loss before taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$8.62M | USD | 1 Quarter |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$143.00K | USD | 1 Quarter |
| Taxes on income |
IncomeTaxExpenseBenefit
|
$21.00K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.76M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Net loss per share: Basic |
EarningsPerShareBasic
|
$-0.05 | USD | 1 Quarter |
| Net loss per share: Basic |
EarningsPerShareBasic
|
$-0.13 | USD | 1 Quarter |
| Net loss per share: Diluted |
EarningsPerShareDiluted
|
$-0.13 | USD | 1 Quarter |
| Net loss per share: Diluted |
EarningsPerShareDiluted
|
$-0.05 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
161.80M | shares | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
154.08M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
161.80M | shares | 1 Quarter |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
154.08M | shares | 1 Quarter |
Cash Flow Statement
48 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-8.76M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$306.00K | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$429.00K | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$2.30M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$2.37M | USD | 1 Quarter |
| Remeasurement of warrant liabilities |
RemeasurementOfWarrantLiabilities
|
$-875.00K | USD | 1 Quarter |
| Remeasurement of warrant liabilities |
RemeasurementOfWarrantLiabilities
|
$189.00K | USD | 1 Quarter |
| Increase in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$800.00K | USD | 1 Quarter |
| Increase in accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$2.82M | USD | 1 Quarter |
| Decrease in other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$4.92M | USD | 1 Quarter |
| Decrease in other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$559.00K | USD | 1 Quarter |
| Increase in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$2.06M | USD | 1 Quarter |
| Increase in accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.21M | USD | 1 Quarter |
| Decrease in deferred revenues |
IncreaseDecreaseInDeferredCharges
|
$1.16M | USD | 1 Quarter |
| Decrease in deferred revenues |
IncreaseDecreaseInDeferredCharges
|
$232.00K | USD | 1 Quarter |
| Decrease in accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$-1.84M | USD | 1 Quarter |
| Decrease in accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$-6.70M | USD | 1 Quarter |
| Other |
IncreaseDecreaseInOtherOperatingLiabilities
|
$105.00K | USD | 1 Quarter |
| Other |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-95.00K | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-15.15M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-14.04M | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$88.00K | USD | 1 Quarter |
| Purchase of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$9.00K | USD | 1 Quarter |
| Proceeds from sale of property and equipment |
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
|
- | USD | 1 Quarter |
| Proceeds from sale of property and equipment |
ProceedsFromSaleOfOtherPropertyPlantAndEquipment
|
$28.00K | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$19.00K | USD | 1 Quarter |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-88.00K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$2.06M | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$621.00K | USD | 1 Quarter |
| Payments for employee taxes withheld related to vested stock-based awards |
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
|
$65.00K | USD | 1 Quarter |
| Payments for employee taxes withheld related to vested stock-based awards |
PaymentsForEmployeeTaxesWithheldRelatedToRestrictedStockUnitsVested
|
$558.00K | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$1.50M | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$556.00K | USD | 1 Quarter |
| Net decrease in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-13.46M | USD | 1 Quarter |
| Net decrease in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-13.73M | USD | 1 Quarter |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$184.53M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$125.08M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$138.54M | USD | Point-in-time |
| Cash and cash equivalents at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$198.26M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$184.53M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$125.08M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$138.54M | USD | Point-in-time |
| Cash and cash equivalents at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$198.26M | USD | Point-in-time |
| Cash paid during the period for interest |
InterestPaidNet
|
$12.00K | USD | 1 Quarter |
| Cash paid during the period for interest |
InterestPaidNet
|
$29.00K | USD | 1 Quarter |
| Cash paid during the period for income taxes |
IncomeTaxesPaidNet
|
$168.00K | USD | 1 Quarter |
| Cash paid during the period for income taxes |
IncomeTaxesPaidNet
|
$174.00K | USD | 1 Quarter |
Stockholders Equity
20 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance, value |
StockholdersEquity
|
$127.54M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$121.64M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Beginning balance, value |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Beginning balance, shares |
CommonStockSharesOutstanding
|
163.12M | shares | Point-in-time |
| Beginning balance, shares |
CommonStockSharesOutstanding
|
161.16M | shares | Point-in-time |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$621.00K | USD | 1 Quarter |
| Exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$2.06M | USD | 1 Quarter |
| Restricted Stock Units Vested |
RestrictedStockUnitsVested
|
$-65.00K | USD | 1 Quarter |
| Restricted Stock Units Vested |
RestrictedStockUnitsVested
|
$-67.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.30M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.37M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.76M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-20.36M | USD | 1 Quarter |
| Ending balance, value |
StockholdersEquity
|
$127.54M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$121.64M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$192.27M | USD | Point-in-time |
| Ending balance, value |
StockholdersEquity
|
$176.28M | USD | Point-in-time |
| Ending balance, shares |
CommonStockSharesOutstanding
|
163.12M | shares | Point-in-time |
| Ending balance, shares |
CommonStockSharesOutstanding
|
161.16M | shares | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.